IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.857
EU - Europa 4.276
AS - Asia 1.761
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 10.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.836
IE - Irlanda 946
CN - Cina 881
UA - Ucraina 773
SE - Svezia 666
TR - Turchia 660
IT - Italia 614
GB - Regno Unito 439
FR - Francia 350
DE - Germania 250
IN - India 179
FI - Finlandia 155
CA - Canada 19
VN - Vietnam 18
RU - Federazione Russa 14
BE - Belgio 13
NL - Olanda 12
PL - Polonia 12
EU - Europa 11
AT - Austria 9
IR - Iran 8
HK - Hong Kong 6
AL - Albania 4
JP - Giappone 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
AU - Australia 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
CL - Cile 2
DK - Danimarca 2
ES - Italia 2
SG - Singapore 2
TT - Trinidad e Tobago 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 10.920
Salva come PNG Salva come JPEG
Città #
Chandler 1.086
Jacksonville 958
Dublin 932
Princeton 383
Ashburn 375
Southend 370
Izmir 335
Nanjing 234
Dearborn 205
Wilmington 185
Beijing 181
Cambridge 159
Ann Arbor 144
Altamura 134
Chieti 104
Nanchang 99
New York 69
Washington 63
Boardman 54
Hebei 48
Shenyang 48
Kunming 44
Woodbridge 44
Tianjin 40
Jiaxing 31
Grevenbroich 30
Norwalk 29
Changsha 28
Los Angeles 28
Augusta 25
Rome 25
Seattle 20
Dong Ket 18
Jinan 18
Changchun 17
Lanzhou 17
Pescara 17
San Mateo 17
Toronto 17
Hangzhou 16
Falls Church 15
Brussels 13
Helsinki 10
Leawood 10
Pune 10
Amsterdam 9
Milan 9
Caserta 8
Ningbo 8
Tappahannock 7
Hong Kong 6
Kocaeli 6
Shanghai 6
Bologna 5
Fairfield 5
Grugliasco 5
Orange 5
Paris 5
Zhengzhou 5
Ancona 4
Cagliari 4
Campobasso 4
Delhi 4
Florence 4
Fuzhou 4
Hefei 4
Houston 4
Monmouth Junction 4
Mountain View 4
Palermo 4
Radomsko 4
Reggio Calabria 4
Teramo 4
Tirana 4
Anzola Dell'emilia 3
Ardabil 3
Catania 3
Denver 3
Edinburgh 3
Frankfurt am Main 3
Guangzhou 3
Kraków 3
Legnano 3
London 3
Naples 3
Rio Saliceto 3
San Vito Chietino 3
Taiyuan 3
Tokyo 3
Wuhan 3
Altino 2
Ascoli Piceno 2
Athens 2
Bari 2
Barrington 2
Bialystok 2
Boscotrecase 2
Budapest 2
Chaoyang 2
Chengdu 2
Totale 6.922
Salva come PNG Salva come JPEG
Nome #
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 113
Role of growth factors in the development of diabetic complications 108
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 105
Pentraxin 3 and platelet activation in obese patients after gastric banding 104
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 104
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 99
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 99
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 98
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 97
Neurocognitive impairment and suicide risk among prison inmates 95
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 94
null 88
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 87
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 87
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 87
Platelet activation in obesity and metabolic syndrome. 86
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 86
The role of nitric oxide in the development of diabetic angiopathy. 84
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 84
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 84
Platelets and Diabetes 84
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 84
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 83
Determinants of platelet activation in hypertensives with microalbuminuria. 82
The role of antileukotrienes in the treatment of asthma. 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 81
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 81
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 80
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 80
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 80
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 79
Platelets and diabetes mellitus 79
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 78
Soluble forms of RAGE in internal medicine. 78
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 77
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 77
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 77
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 76
Atherothrombotic disease and the metabolic syndrome. 76
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 76
Coagulation and infective endocarditis: sooner or later 75
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 75
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 75
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 74
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 74
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 73
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 73
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 73
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 73
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 73
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 72
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 71
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 71
Soluble RAGE in type 2 diabetes: association with oxidative stress. 70
Aterosclerosi ed aterosclerosi accelerata: ruolo e meccanismi dell’immunoflogosi. 70
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 70
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 70
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 69
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 69
The left atrial appendage: from embryology to prevention of thromboembolism 69
Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach 69
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 68
Nutraceuticals in diabetes and metabolic syndrome. 67
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 67
CD40 ligand and MCP-1 levels as predictors of cardiovascular events in lacunar and non-lacunar strokes. 67
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 67
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 67
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 67
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 67
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 67
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 66
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 66
Effectiveness of Montelukast versus Budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma 66
Unveiling the inflammatory face of antiplatelet drugs. 65
Enhanced soluble CD40 ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control 65
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 65
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 64
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 64
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 64
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 64
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 64
Oxidative stress in chronic vascular disease: From prediction to prevention 64
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever 64
Aspirin as antiplatelet agent in diabetes. PROS-. 64
Thrombin as a common downstream target blocking both platelet and monocyte activation 63
Association between PAI-1 and Oxidative Stress in Android Obesity 63
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 63
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 63
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. 62
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 62
Insulin resistance as a determinant of platelet activation in obese women 62
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 62
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 62
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 62
Association between enhanced soluble CD40 ligand and platelet activation in hypertensives with microalbuminuria. 62
Diabetes mellitus 61
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 61
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 61
Determinants of platelet activation in hypertensives with microalbuminuria. 61
Totale 7.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019393 0 0 0 0 0 0 0 0 0 5 15 373
2019/20202.402 679 149 32 37 207 141 290 227 89 294 235 22
2020/20211.105 191 17 202 20 58 242 31 28 102 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.558 104 44 119 51 131 551 363 107 39 49 0 0
Totale 11.978